<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_FTBdBsh">Adapting a Text Messaging Intervention to Improve Diabetes Medication Adherence in a Spanish-Speaking Population: Qualitative Study</title>
				<funder ref="#_WkZW52u">
					<orgName type="full">National Institute of Diabetes and Digestive and Kidney Diseases</orgName>
					<orgName type="abbreviated">NIDDK</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100000062</idno>
				</funder>
				<funder ref="#_P7jKgUm">
					<orgName type="full">MGH</orgName>
				</funder>
				<funder ref="#_rav5sfR">
					<orgName type="full">American Diabetes Association</orgName>
					<orgName type="abbreviated">ADA</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100000041</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Jacqueline</forename><surname>Seiglie</surname></persName>
							<email>jseiglie@mgh.harvard.edu</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Medicine , Harvard Medical School , Boston , MA , United States</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Diabetes Unit , Massachusetts General Hospital , Boston , MA , United States</note>
								<orgName type="department">Diabetes Unit</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Seth</forename><surname>Tobolsky</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Diabetes Unit , Massachusetts General Hospital , Boston , MA , United States</note>
								<orgName type="department">Diabetes Unit</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ricaurte</forename><surname>Crespo Trevino</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Mass General Brigham Salem Hospital , Salem , MA , United States</note>
								<orgName type="institution">Mass General Brigham Salem Hospital</orgName>
								<address>
									<settlement>Salem</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Lluvia</forename><surname>Cordova</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Diabetes Unit , Massachusetts General Hospital , Boston , MA , United States</note>
								<orgName type="department">Diabetes Unit</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>BS</roleName><forename type="first">Sara</forename><surname>Cromer</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Medicine , Harvard Medical School , Boston , MA , United States</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Diabetes Unit , Massachusetts General Hospital , Boston , MA , United States</note>
								<orgName type="department">Diabetes Unit</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Enrique</forename><surname>Caballero</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Division of Endocrinology, Diabetes and Hypertension , Brigham and Women&apos;s Hospital , Boston , MA , United States</note>
								<orgName type="department">Division of Endocrinology, Diabetes and Hypertension</orgName>
								<orgName type="institution">Brigham and Women&apos;s Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Margarita</forename><surname>Alegria</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> Disparities Research Unit , Department of Medicine , Massachusetts General Hospital , Boston , MA , United States</note>
								<orgName type="department" key="dep1">Disparities Research Unit</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> Departments of Medicine &amp; Psychiatry , Harvard Medical School , Boston , MA , United States</note>
								<orgName type="department">Departments of Medicine &amp; Psychiatry</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Jaime</forename><surname>Miranda</surname></persName>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>7</label> Sydney School of Public Health , Faculty of Medicine and Health , University of Sydney , Sydney , Camperdown , Australia</note>
								<orgName type="department" key="dep1">Sydney School of Public Health</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Sydney Camperdown</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD;</roleName><forename type="first">Deborah</forename><surname>Wexler</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Medicine , Harvard Medical School , Boston , MA , United States</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Diabetes Unit , Massachusetts General Hospital , Boston , MA , United States</note>
								<orgName type="department">Diabetes Unit</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MSc</roleName><forename type="first">Lindsay</forename><surname>Mayberry</surname></persName>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>8</label> Vanderbilt University Medical Center , Nashville , TN , United States Diabetes Unit</note>
								<orgName type="department">Diabetes Unit</orgName>
								<orgName type="institution">Vanderbilt University Medical Center</orgName>
								<address>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Crespo</forename><surname>Ricaurte</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lluvia</forename><surname>Trevino</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sara</forename><surname>Cordova</surname></persName>
						</author>
						<author>
							<persName><surname>Cromer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Margar- Ita</forename><forename type="middle">J</forename><surname>Alegria</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lindsay</forename><forename type="middle">Mayberry</forename><surname>Originally</surname></persName>
						</author>
						<author>
							<affiliation key="aff8">
								<note type="raw_affiliation">Massachusetts General Hospital 50 Staniford St , Suite 340 Boston , MA , 02114 United States</note>
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<addrLine>50 Staniford St Suite 340</addrLine>
									<postCode>02114</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_ayE9AVM">Adapting a Text Messaging Intervention to Improve Diabetes Medication Adherence in a Spanish-Speaking Population: Qualitative Study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">09AADDD229E4BCC19F487D7997B0AFB5</idno>
					<idno type="DOI">10.2196/66668</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T10:52+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_KzE243v">diabetes</term>
					<term xml:id="_8gD4U7X">diabetes mellitus</term>
					<term xml:id="_WvMsF98">DM</term>
					<term xml:id="_JV6bkZ9">type 2 diabetes</term>
					<term xml:id="_VaTreMx">T2DM</term>
					<term xml:id="_nGtvBVp">type 1 diabetes</term>
					<term xml:id="_qZKC2uD">endocrinology</term>
					<term xml:id="_YDdXjfY">medication adherence</term>
					<term xml:id="_Tsp3aVm">adherence</term>
					<term xml:id="_M8YhKPk">Latino adults</term>
					<term xml:id="_dV8E6m9">stakeholder engagement</term>
					<term xml:id="_nJSNPap">text messaging</term>
					<term xml:id="_7sTEcKe">messaging</term>
					<term xml:id="_ANWHAuN">intervention</term>
					<term xml:id="_kYXZNng">multiphase</term>
					<term xml:id="_gHQAAEa">nonadherence</term>
					<term xml:id="_9EUuHaF">glycated hemoglobin</term>
					<term xml:id="_NMZGTm3">HbA1c</term>
					<term xml:id="_F9fyHkZ">Latino</term>
					<term xml:id="_49sUQed">stakeholder</term>
					<term xml:id="_JYDexAE">medication</term>
					<term xml:id="_9TrjE5E">Spanish-speaking</term>
					<term xml:id="_8eRXVCY">population</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_gjpPwBG"><p xml:id="_j9CbAM6"><s xml:id="_E4Nf5ps">Background: Latino adults with type 2 diabetes (T2D) have higher rates of diabetes medication nonadherence than non-Hispanic White adults.</s><s xml:id="_3Xdp6cA">REACH (Rapid Encouragement/Education And Communications for Health) is a text message platform based on the information-motivation-behavioral skills model that addresses barriers to adherence and was shown to improve adherence and glycated hemoglobin (HbA1c) levels, but it is only available in English.</s></p><p xml:id="_wXpRDCF"><s xml:id="_fW43Fmf">Objective: This study aimed to report the multiphase, stakeholder-driven adaptation of the REACH barriers to diabetes medication adherence content to a Latino population (REACH-Español).</s><s xml:id="_2tzrTv9">Methods: This was a qualitative study using focus groups.</s><s xml:id="_8dtJGsN">We identified potentially eligible patients (≥18 y old, Latino ethnicity, Spanish-language preference, and T2D diagnosis) using a Mass General Brigham Hospital query.</s><s xml:id="_tqb87NA">Eligible patients were invited to participate in a focus group conducted in Spanish between April 13 and November 9, 2023.</s><s xml:id="_ydkKYd7">A total of 5 focus groups were conducted.</s><s xml:id="_Rzp2ZD7">Focus groups 1-3 centered on ranking 40 barriers to diabetes medication adherence (derived from REACH and the extant literature), whereas focus groups 4-5 centered on translation and cultural modifications of the original SMS text message content associated with each of the REACH barriers.</s><s xml:id="_nZzWeHw">Barriers were mapped onto informationmotivation-behavioral constructs.</s><s xml:id="_AEbCWqC">We used descriptive statistics to summarize participant characteristics.</s><s xml:id="_hwgzGEM">Focus groups were audio-recorded, professionally transcribed, and analyzed with thematic content analysis using NVivo (Lumivero).</s><s xml:id="_v9mYx7U">Results: In total, 22 participants attended the focus groups.</s><s xml:id="_mgVtPVZ">The mean (SD) age was 63.2 (11) years, 55% (n=10/22) were female, and the mean HbA1c level was 8.5%.</s><s xml:id="_fUCM2En">All participants were born in Latin America or the Caribbean and spoke Spanish as their preferred language, and 54.5% (12/22) had completed middle-school education or less.</s><s xml:id="_zEDT5kV">Among the top 10 ranked barriers, 50% (n=5) corresponded to information, 20% (n=2) to social motivation, 20% (n=2) to behavioral skills, and 10% (n=1) to personal motivation.</s><s xml:id="_HnWMuP3">Personal motivation barriers (medication burden and fear of side effects) and behavioral skills (forgetting to take medication) emerged as important themes in the focus groups.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.28" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WdFFZaY">Introduction</head><p xml:id="_eNkF7Fw"><s xml:id="_3m2SQr4">Suboptimal medication adherence, generally defined as taking less than 80% of prescribed medications <ref type="bibr" target="#b0">[1]</ref>, is reported by nearly 50% of adults with type 2 diabetes (T2D) <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref> and is associated with poor glycemic management <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b3">4]</ref> and higher risk of all-cause mortality <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_8kMFtRJ">Rates of suboptimal diabetes medication adherence are higher in racial and ethnic minority populations <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>, particularly among individuals with lower English language proficiency <ref type="bibr" target="#b7">[8]</ref>.</s><s xml:id="_5ejA8bq">An estimated 60% of Latino adults with limited English language proficiency report nonadherence to diabetes medications, compared with 52% of Latino adults with English proficiency and 38% of non-Hispanic White individuals <ref type="bibr" target="#b7">[8]</ref>.</s><s xml:id="_jMrUceZ">Unique barriers to diabetes medication adherence have been reported by Latino adults with T2D <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>, including negative perceptions regarding diabetes medication use (particularly insulin) <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b17">18]</ref>, misunderstanding of the ongoing need for glucose-lowering pharmacotherapy once glycated hemoglobin (HbA1c) has improved <ref type="bibr" target="#b16">[17]</ref>, and challenges with regimen complexity even with the use of a Spanish-language interpreter <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s xml:id="_7EMNUQh">While interventions that address patient-reported barriers to diabetes medication adherence can improve glycemic management <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b20">21]</ref>, interventions that address barriers to diabetes medication adherence of relevance to Latino adults with T2D are lacking.</s></p><p xml:id="_MUnvSvC"><s xml:id="_DJnRCgj">Among numerous behavioral theories that explain medication adherence behavior <ref type="bibr" target="#b21">[22]</ref>, the information-motivation-behavioral skills (IMB) model is an important theorybased model for conceptualizing and addressing domains associated with diabetes medication adherence <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s xml:id="_vKeNqXE">The IMB model is built on three key components that influence behavior change, that are (1) information (ie, accurate knowledge about the disease and medications), ( <ref type="formula">2</ref>) motivation (ie, beliefs and attitudes plus social support and social norms), and (3) behavioral skills (ie, objective and perceived abilities) <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b24">25]</ref>.</s><s xml:id="_N3vxQ7G">When applied to diabetes medication adherence behavior, the IMB components allow for the identification of barriers to medication adherence in each domain <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_gUcXJBs">Several interventions that have incorporated this model to address self-reported barriers to medication adherence have shown improvements in diabetes medication adherence and glycemic management among adults with T2D, including among Latino adults <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b22">23]</ref>.</s><s xml:id="_acGwQt7">However, patient-centered tools for Latino adults with T2D based on the IMB model that are scalable and that do not rely on in-person educational sessions, which can be resource-intensive, do not yet exist.</s><s xml:id="_HWBHChg">REACH (Rapid Encouragement/Education And Communications for Health) is an innovative text message tool based on the IMB model that delivers text message content tailored to individual patient-reported barriers to diabetes medication adherence <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b25">26]</ref>.</s><s xml:id="_SQJqzST">REACH delivers daily diabetes self-management 1-way texts, daily 2-way texts that ask about medication adherence, and weekly texts that provide adherence feedback and encouragement based on responses to 2-way texts.</s><s xml:id="_DkKNnTC">REACH was shown to improve diabetes medication adherence (by an average of one-third to one-half day per week over 12 months), reduce barriers to diabetes medication adherence (including cost-related barriers), improve dietary behavior and physical activity, and significantly reduce HbA1c at 6 months compared with usual care (0.74% reduction among patients with baseline HbA1c≥8.5%)</s><s xml:id="_bT9PcJ9"><ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_q2GNVBA">However, despite its efficacy, scalability, and high participant engagement <ref type="bibr" target="#b26">[27]</ref>, REACH has not been adapted to other contexts.</s><s xml:id="_bjrZ27Z">REACH could serve as an important clinical tool to address barriers to diabetes medication adherence among Latino adults with T2D.</s><s xml:id="_WnDJeYr">In this study, we used a multistage, stakeholder-driven, iterative method of language adaptation to adapt the original REACH barrier content to a Latino, Spanish-speaking population with T2D, focusing on identifying barriers to diabetes medication adherence of relevance to this population.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5bYVpDQ">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vFKrrTR">Study Design, Setting, and Participant Eligibility</head><p xml:id="_EpUhNbW"><s xml:id="_STZp92Z">We conducted a qualitative study by carrying out focus groups at the Massachusetts General Hospital (MGH) Chelsea HealthCare Center, one of the MGH Community Health Care Centers that serve a patient population in the greater Boston area that is majority Latino or Spanish-speaking <ref type="bibr" target="#b27">[28]</ref>.</s><s xml:id="_FYAVgQf">Eligible participants had a T2D diagnosis (based on diagnostic codes, confirmed with electronic health record review), were ≥18 years old, were taking at least 1 glucose-lowering medication, and reported Spanish as their preferred written and spoken language.</s><s xml:id="_Cw2Yjxx">We excluded patients with auditory or communication difficulties.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NJnDamZ">Participant Recruitment</head><p xml:id="_zKeeU4h"><s xml:id="_ZBdgZg3">We searched the MGH Research Patient Data Registry to identify individuals who received care at MGH within the previous 2 years and who were ≥18 years old, had a diagnosis of T2D, and had registered Spanish as their preferred language.</s><s xml:id="_QFWhk9X">A total of 3709 patients met this criteria, of whom 500 lived in the city of Chelsea.</s><s xml:id="_vBm8MYE">We mailed out opt-out letters to 350 of these participants (selected randomly), followed by telephone calls to screen for the eligibility criteria described above.</s><s xml:id="_zJ65uwx">Among 30 eligible patients willing to participate in the study, 22 unique participants attended one of the focus groups 1-5.</s><s xml:id="_2T3FQRs">A total of 10 participants who attended focus groups 1-3 also attended either focus group 4 or 5.</s><s xml:id="_ukWQhZU">The reason for participation in multiple focus groups was to engage patients in the iterative process of content adaptation, which took place in two steps: (1) identification of barriers to diabetes medication adherence of relevance to the study population (focus groups 1-3) and (2) adaptation of SMS text message content addressing the relevant barriers.</s><s xml:id="_QghA8Qz">Enrollment occurred between March and November of 2023.</s><s xml:id="_tS3zGBK">Given that the original REACH content was created with input from communication experts who edited the text messages to be readable and understandable (ie, written at the sixth-grade reading level or below) <ref type="bibr" target="#b25">[26]</ref>, the adaptation of REACH barrier content was also guided by an emphasis on reading appropriateness for the study population.</s><s xml:id="_dTeV4R7">Thus, for eligible patients interested in participating in the study, we conducted a health literacy screening to tailor the focus group activities to the literacy level of the study population.</s><s xml:id="_9BehW7K">We used the 1-item Brief Health Literacy Screening Tool (BRIEF) questionnaire ("How confident are you filling out medical forms by yourself?"),</s><s xml:id="_KuR2gh5">which has been validated for Spanishspeaking populations as a quick assessment of health literacy <ref type="bibr" target="#b28">[29]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7QkTThY">Ethical Considerations</head><p xml:id="_RbFUFjD"><s xml:id="_JGC2c2F">Participants received US $50 for focus group attendance.</s><s xml:id="_WPPNgyj">The Mass General Brigham Institutional Review Board approved all aspects of the study (protocol 2022P002678).</s><s xml:id="_jNKEZ4B">At the beginning of each focus group, participants received an IRB-approved information sheet, which outlined the objectives of the study, procedures, benefits and risks, confidentiality, as well as an emphasis on voluntary participation.</s><s xml:id="_sGct9zG">All participants agreed to participate in the focus groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wbJhXVb">Measures</head><p xml:id="_8aXrKeg"><s xml:id="_DUmRYdj">At the start of each focus group, participants were asked to fill out a sociodemographic and diabetes history questionnaire.</s><s xml:id="_db2GSX3">The data that were collected through this questionnaire were age, sex, ethnicity, country of birth, preferred language, educational attainment, household income, health insurance, and diabetes history (age at diagnosis, diabetes medications, and complications).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_n6WZyMv">REACH Barriers to Diabetes Medication Adherence</head><p xml:id="_hjWcFNE"><s xml:id="_rMdwVsb">The development of the REACH barrier content has been described in studies by Nelson et al <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref>.</s><s xml:id="_9Kr2KT3">The REACH study team conducted a thorough review of published studies describing patient-reported barriers to adherence to glucoselowering medications.</s><s xml:id="_seYNvq2">The literature review yielded 68 barriers to taking oral glucose-lowering medications and 7 barriers to taking insulin; similar barriers were collapsed, resulting in 36 adherence barriers <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_y4A8ePn">A 2-step interactive procedure was subsequently used to rank these barriers among adults with T2D.</s><s xml:id="_nm7DZQD">Each of the 36 barriers was mapped to the IMB constructs, and content experts drew on identified studies to develop SMS text messages addressing each barrier <ref type="bibr" target="#b25">[26]</ref>.</s><s xml:id="_ZB2hk3A">For instance, the barrier "My daily medicine routine is too complicated to keep track of" generated 21 SMS text messages to address this concern, such as "to help keep things simple, take your medications at the same time you're doing something else, like brushing your teeth or eating meals."</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mbk65rr">Adaptation Methodology</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DxpDFb4">Description</head><p xml:id="_TC96zME"><s xml:id="_dNTj78q">To ensure that the REACH-Español barrier content was culturally and linguistically appropriate for the target population, we were guided by the multistage, iterative method for cross-cultural adaptation proposed by Matías-Carrelo et al <ref type="bibr" target="#b29">[30]</ref> This multistage method relies on the linguistic review of the translated instrument by incorporating input from multiple stakeholders, including both a multinational bilingual committee composed of bilingual (English-Spanish) researchers familiar with the instrument and stakeholders from the populations being studied.</s><s xml:id="_29VFvVD">This adaptation methodology aims to maintain the content, semantic, and technical equivalence.</s><s xml:id="_Kt2KWKR">It is superior to the translation and back-translation method, which may not yield cultural equivalency of the content being translated, nor capture key sociocultural factors <ref type="bibr" target="#b29">[30]</ref>.</s><s xml:id="_QNhPRRS">In this study, two groups of bilingual stakeholders reviewed the SMS text message content being translated (1) a bilingual research team and (2) focus group participants.</s><s xml:id="_9gv9WX9">Figure <ref type="figure" target="#fig_0">1</ref> summarizes the 10-step adaptation process used in this study (the Matías-Carrelo et al <ref type="bibr" target="#b29">[30]</ref> framework is shown in gray and the corresponding adaptations in white).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_j3ndfkB">Literature Review of Barriers and Translation</head><p xml:id="_CgU5ZXT"><s xml:id="_2Jwm422">We conducted a systematic review of published studies describing patient-reported barriers to diabetes medication adherence in Spanish-speaking adults with T2D.</s><s xml:id="_5aTBajM">We identified an additional 9 barriers relevant to Spanish-speaking adults that were not included in the original REACH barrier list (Multimedia Appendix 1).</s><s xml:id="_BXZUyby">We collapsed similar barriers, resulting in 40 barriers to diabetes medication adherence with potential relevance to Spanish-speaking adults with T2D (Multimedia Appendix 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AdcGW9Q">Barrier Translation</head><p xml:id="_gewAstq"><s xml:id="_vVdeKsf">The 40 barriers' names were professionally translated into Spanish (Multimedia Appendix 1).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_39bCEPJ">Barrier Assessment</head><p xml:id="_WrYWVPM"><s xml:id="_Vz8CXPC">To assess the relevance (and irrelevance) of the 40 barriers to diabetes medication adherence among Latino adults with T2D, we conducted 3 focus groups.</s><s xml:id="_2c6NjgX">Our screening for health literacy at recruitment showed that 33% of participants interested in attending one of the focus groups had low health literacy ("not at all" confident in filling out medical forms by yourself).</s><s xml:id="_enw2qWt">Therefore, we tailored the focus group activities to a lower health literacy level by focusing on nonwritten activities and using visual props and cues to guide the discussion (Multimedia Appendix 3).</s><s xml:id="_r2j5gzh">We used a 2-step interactive process adapted from the original REACH barrier development process <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_2rrY7jy">In the first activity, we encouraged an open discussion by asking participants to think about "things that make taking diabetes medications difficult" and to share these with the group; we wrote each item on a whiteboard as the discussion progressed.</s><s xml:id="_YuBTx3N">In the second activity, we asked participants to rank each of the 40 barriers to diabetes medication adherence referenced earlier, according to personal relevance.</s><s xml:id="_BM5CrQH">To make the activity easy to follow, we used a "traffic light" model of 3 colored envelopes and asked participants to place each written barrier name (eg, "I worry that taking diabetes medicines for a long time will be bad for me") into a folder, based on its relevance to them (Multimedia Appendix 3): red (never), yellow (sometimes), or green (always).</s><s xml:id="_kpRKB7E">Focus groups were audio-recorded and professionally transcribed in Spanish.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Gmzj2tb">Barrier Analysis and Selection</head><p xml:id="_rGU4nP2"><s xml:id="_ARxNf3J">Upon completion of the barrier ranking activity, barriers that were placed in the red "never" envelope received a score of 1, those placed in the yellow "sometimes" folder received a 2, and barriers placed in the green "always" folder received a 3. We then calculated the proportion of participants that reported each barrier as sometimes or always (Multimedia Appendix 4).</s><s xml:id="_2FtP7mj">We retained 23 barriers that were reported as relevant ≥33% of participants (mean proportion for all barriers was 32%) plus 1 barrier (regimen complexity) that emerged as an important theme in the focus groups.</s><s xml:id="_MRt8GJY">We then combined barriers with similar content (19 barriers) and removed 1 barrier ("I think brand name medicine works better than generic medicine") because of some recent recalls of generic glucose-lowering medications which may have affected perceptions at the time <ref type="bibr" target="#b30">[31]</ref>, resulting in 18 final barriers for REACH-Español.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6j7VEPw">Review of Existing Barrier Text Message Content</head><p xml:id="_pfBWTj5"><s xml:id="_H6UDhwS">To adapt the text message content corresponding to each barrier in a Spanish-speaking population, we selected the most relevant barriers that were identified in focus groups 1-3.</s><s xml:id="_9gyBbaY">We reviewed the original REACH text message English content corresponding to each of the selected barriers and conducted a readability check of each text message using the Flesch-Kincaid readability grade level test, ensuring that the language used was grade 6 or lower.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6BfkgeA">Text Message Content Translation</head><p xml:id="_e3AgnqQ"><s xml:id="_rswBCSX">The text message content corresponding to each of the 18 barriers was professionally translated into Spanish.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9t2DJmD">Text Message Spanish Language Assessment</head><p xml:id="_eTdRy3r"><s xml:id="_zpHWP35">To ensure that the Spanish text message content was culturally and linguistically appropriate for the target population, we invited the same group of participants that attended focus groups 1-3 to attend 1 of 2 additional focus groups (focus groups 4-5).</s><s xml:id="_TA8YCfw">To solicit participant feedback in the focus groups, we projected each text message on a Microsoft PowerPoint presentation and gave each participant a green ("Yes) and a red ("No") paddle (Multimedia Appendix 5).</s><s xml:id="_zQRd7mV">We asked participants to approve or disapprove of messaging according to ease of understanding by raising the paddle when each text message was projected and read aloud.</s><s xml:id="_kEDvY6f">We discussed messages that received "No" votes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fYjYfkm">Text Message Content Modification</head><p xml:id="_Yn922B2"><s xml:id="_XHZ5Jpk">Following the completion of focus groups 4-5, we excluded text messages not well-received by participants (not relevant, tone did not resonate).</s><s xml:id="_XTfChRY">Then, our bilingual research team modified specific language based on participant feedback, with a focus on selecting language that was more broadly understood by Spanish-speaking participants from diverse geographic and cultural backgrounds with distinct dialects.</s><s xml:id="_PHjem9f">Focus groups were audio-recorded and professionally transcribed in Spanish.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_eYC8gKv">Beta Testing</head><p xml:id="_ThWgET2"><s xml:id="_T8qCubM">The revised text message content was sent to our digital health partner, MEMOTEXT, which will deliver the text messages to participants in the pilot study of REACH-Español.</s><s xml:id="_xP9erVm">To ensure that the text message content delivery worked as intended and to subject the content to one more round of language modification, we conducted beta testing of the text message content.</s><s xml:id="_uMBK99Z">Beta testing entailed having the research team members as well as 3 patient stakeholders (participants who attended focus groups 4 or 5) receive and interact with the REACH-Español text message content over the course of 4 weeks.</s><s xml:id="_sRg6exF">All members of the beta testing process provided input on a weekly basis on either technical or linguistic aspects that required modification.</s><s xml:id="_SWbc6Rd">Patient stakeholders provided their impression of the program via an exit interview.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_X7WN9ZT">Fine-Tuning</head><p xml:id="_eyFNf5g"><s xml:id="_y7pY6gH">Throughout the beta testing process, we identified several technical issues, mostly pertaining to the sent time of the text messages (ie, too close to bedtime, welcome text message sent after content message).</s><s xml:id="_SHSZQZV">MEMOTEXT revised the platform throughout the beta testing process based on user feedback.</s><s xml:id="_QaCxGrK">After all user input was incorporated, a final version of the REACH-Español text message content was created.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JckTzsj">Analysis</head><p xml:id="_468kNcx"><s xml:id="_4MZSuDa">We used descriptive statistics (means, SDs, and proportions) to summarize participant characteristics.</s><s xml:id="_fa9WyMw">For the qualitative analysis, an "open-coding" approach (inductive) was used first to identify themes in the transcripts (in Spanish) from focus groups 1-3.</s><s xml:id="_MpyTcsa">Themes were then categorized as barriers and facilitators to diabetes medication adherence.</s><s xml:id="_E6AerYK">Second, we used deductive coding to map the codes into the IMB construct.</s><s xml:id="_dk9DyGe">Coding was conducted by native Spanish-speaking research team members.</s><s xml:id="_2BfCFH6">Analyses were conducted using Microsoft Excel and NVivo 14 (Lumivero).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FrA5v4h">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_f58S3JX">Focus Group Participants</head><p xml:id="_RvPRaeB"><s xml:id="_dpp4fFp">A total of 22 participants attended focus groups 1-5.</s><s xml:id="_TjsMFBZ">The first 3 groups were attended by 18 participants; 10 of these participants also attended either focus group 4 or 5.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_aWNKppv">Barrier Selection</head><p xml:id="_rSs9vR8"><s xml:id="_DQfqwVS">Multimedia Appendix 2 shows the list of 40 barriers to diabetes medication adherence that were assessed for relevance in focus groups 1-3.</s><s xml:id="_NxtYM3g">Barriers are shown in order of higher to lower proportion of participants reporting each barrier as relevant sometimes or always.</s><s xml:id="_cTxPFMM">Figure <ref type="figure" target="#fig_1">2</ref> shows the list of 40 barriers, categorized into the IMB model and ranked according to the proportion of participants who reported the barrier as relevant sometimes or always.</s><s xml:id="_DHrXGSR">Among the top 10 barriers, 50% (n=5) corresponded to the information category, 20% (n=2) to the social motivation category, 20% (n=2) to behavioral skills, and 10% (n=1) to personal motivation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PVNwaj8">Barriers to Diabetes Medication Adherence Based on Thematic Analysis</head><p xml:id="_gtdnqRn"><s xml:id="_jK6x3Qt">Table <ref type="table" target="#tab_1">2</ref> outlines the key themes that emerged in focus groups 1-3 based on participant quotes, grouped into barriers to diabetes medication adherence, and mapped into the IMB model.</s><s xml:id="_8B3mPNV">In total, 5 themes emerged in response to the question "What are some difficulties that come to mind when taking your diabetes medications?"</s><s xml:id="_r7MFGzA">In order of relevance (higher or lower number of times mentioned), most participants agreed that medication burden was one of the most important barriers to diabetes medication adherence, followed by fear of side effects or of new medication, difficulty or confusion with medication changes, forgetting to take medications, and frustration with diagnosis or lack or improvement.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bCAWnK4">Facilitators to Diabetes Medication Adherence Based on Thematic Analysis</head><p xml:id="_j6Sbtau"><s xml:id="_sMZ54H5">Multimedia Appendix 6 shows the 5 themes that emerged in response to the question, "What motivates you to take your diabetes medications."</s><s xml:id="_Z2hUZNg">In order of relevance (higher to lower), fear as motivation was an important facilitator, followed by belief in treatment benefit, personal responsibility, and will to take medications, family support and medication organization, and getting used to the medication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_z7gRsF2">Language Modification of Text Message Content</head><p xml:id="_BpKm7mq"><s xml:id="_j5wYh5Z">Focus groups 4-5, which centered on eliciting feedback on the translated text message language content, generated rich discussion.</s><s xml:id="_8gg3c67">A total of 111 text messages (related to barriers 1-8) were reviewed in focus group 4 and 100 text messages (related to barriers 9-18) were reviewed in focus group 5. Participants were generally enthusiastic about the text message content and provided feedback on wording that seemed confusing, too complex, or less likely to be understood by broad Spanish-speaking audiences.</s><s xml:id="_9WQQdre">For instance, the word "comprimidos" was changed to "pastillas" and the preferred word for refills was "reposiciones" instead of "prescripciones."</s><s xml:id="_vGDcXJE">In total, 12 messages were excluded since patients did not like the tone, felt that they were difficult to understand, or felt that they were not relevant.</s><s xml:id="_f9uRQQb">Some examples of these excluded text messages included "If taking your diabetes medications is unpleasant, try to push through.</s><s xml:id="_V9mJc6r">Remember that not taking them may make you feel worse" and "What advice would you give your friends who forget to refill their medications?</s><s xml:id="_9vNfGxH">Use those tips for yourself too!"</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_q7Qby9X">Beta Testing Patient Stakeholder Input</head><p xml:id="_8zM2ndE"><s xml:id="_rnGxtnV">In the final step of REACH-Español content adaptation, 3 patient participants who had attended one of the focus groups were invited to participate in the beta testing process over the course of 4 weeks.</s><s xml:id="_gQynSZV">At the end of beta testing, the following patient stakeholder input was provided:</s></p><p xml:id="_un3XVCv"><s xml:id="_Hjr2A2g">The texts are very important because when you are old, you know things from experience, but you forget things that are important.</s><s xml:id="_A3tu4fc">Like that the test strips need to be in a hermetically sealed box.</s><s xml:id="_DuX74Ef">The text messages are very helpful with remembering to take the medications.</s><s xml:id="_fNMamgm">[Male, 77 years old, Guatemala] The texts are helping to remind me to take my medications.</s><s xml:id="_69WJ2sh">When I look and I see the message [any of the messages], I run to take my medication.</s><s xml:id="_xKgnUjX">The texts are very clear.</s><s xml:id="_JEf3r9n">It's really helping me.</s><s xml:id="_457Mewa">[Female, 45 years old, Guatemala] The content is helpful.</s><s xml:id="_2Ed4Pc8">For example, learning about what food to eat to raise a low blood sugar.</s><s xml:id="_NW7zRKj">It's helping to remind me to take my medications.</s><s xml:id="_npzkj7w">I think this program is best for older people who have the time and attention to follow the advice.</s><s xml:id="_T9jFapu">[Male, 63 years old, El Salvador]</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5SV4rH6">Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dYvAuAK">Principal Findings and Comparison With Previous Works</head><p xml:id="_zQ5CCrn"><s xml:id="_j2Mswv9">In this study, we outline the multistage process used to adapt the REACH text message content <ref type="bibr" target="#b25">[26]</ref>, which addresses patient-reported barriers to diabetes medication adherence, to a Latino population.</s><s xml:id="_ssxJCnf">The adaptation process centered on the theory-based IMB skills model for medication adherence and engagement of patient stakeholders to identify barriers to diabetes medication adherence with specific relevance to Latino adults with T2D (with Spanish-speaking preference).</s></p><p xml:id="_YJpMKbJ"><s xml:id="_watF6D5">We found that among the top 10 most commonly reported barriers to diabetes medication adherence among Latino adults with diabetes, 50% (n=5) corresponded to information gaps, 20% (n=2) to social motivation, 20% (n=2) to behavioral skills, and 10% (n=1) to personal motivation.</s><s xml:id="_MDmE4mG">In contrast, our thematic analysis showed that personal motivation barriers (medication burden and fear of side effects) were the highest concern for focus group participants, followed by behavioral skills (forgetting to take medications), and information barriers (difficulty or confusion with medication changes and frustration with diagnosis or lack of improvement).</s><s xml:id="_ngxSCcZ">These findings suggest that using the IMB model as a framework to identify barriers to diabetes medication adherence is useful in this population and that different qualitative approaches (open discussion vs ranking exercise) can provide complementary data to inform the adaptation process of tailored interventions.</s></p><p xml:id="_YUYwpfv"><s xml:id="_9yYnMpM">By engaging focus group participants in an interactive barrier ranking exercise conducted through card sorting, we were also able to select highly relevant barriers to diabetes medication adherence and exclude those with lower salience from the study.</s><s xml:id="_YuFPcHc">Through this exercise, we found that the priority of some barriers differed in this population compared with the original REACH intervention.</s><s xml:id="_jB3Wv6t">For instance, "I'm not sure what my diabetes medicine is supposed to do" was reported as relevant by 61% (11/18) of participants in this study, whereas this barrier was relevant only for 16% (38/237) of participants in the REACH development study <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_4CzJQfT">Similarly, "I am not sure why my doctor sometimes changes my dose or type of medicine" was relevant to 50% (9/18) of participants in this study, whereas only 15% (36/237) of participants in the REACH development study reported that this barrier was relevant.</s><s xml:id="_BXPe6hc">These findings underscore the importance of stakeholder-driven adaptation approaches given that core intervention components (in this case, the list of barriers), differed across populations.</s></p><p xml:id="_QZNHHPu"><s xml:id="_gev2HFE">We also found that the iterative process of translating and modifying the original intervention content with stakeholder input (bilingual research team, focus group participants) enriched the adaptation process by incorporating language diversity and nuance.</s><s xml:id="_aZVdP6R">By eliciting input from participants through interactive focus group activities, we were able to capture both the thematic and linguistic or cultural relevance of the content being translated.</s><s xml:id="_QtF8BXA">For instance, we excluded certain text messages that did not resonate with the audience.</s><s xml:id="_4wXMtFC">We revised the language with modifications considered more broadly understood across Spanish-speaking Latin American and Caribbean populations.</s><s xml:id="_FmEM7z5">Choosing language wording with a broader reach was particularly important in this study given the heterogeneity of the Spanish language across Latin America and the Caribbean.</s><s xml:id="_wqHamBQ">Our observations are consistent with previous studies that have highlighted the importance of engaging bilingual stakeholders (including patients) throughout the language adaptation process <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33]</ref>.</s></p><p xml:id="_bd3jhDY"><s xml:id="_MMA3kGd">Although barriers to diabetes medication adherence have been previously reported in the Latino population <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b33">34]</ref>, most studies have not used a theoretical framework to identify such barriers.</s><s xml:id="_EtHs3nK">The IMB model has been empirically validated as a framework to identify barriers to diabetes medication adherence <ref type="bibr" target="#b22">[23]</ref>, but only 1 intervention based on the IMB model has documented its use in Latin American adults with diabetes <ref type="bibr" target="#b34">[35]</ref>.</s><s xml:id="_93MaFVE">Our study supports the use of the IMB framework to better ascertain barriers to diabetes medication adherence among Latino adults, which can be helpful in the development of interventions to address these barriers.</s><s xml:id="_ayexHgk">Our qualitative analysis also highlights the importance of treatment complexity in this patient population and underscores the need for interventions that can identify and reduce treatment burden and regimen complexity.</s><s xml:id="_cyRchj3">Although these challenges to diabetes self-management have been well described <ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref>, scalable interventions that can reduce the treatment burden are lacking, particularly in the Latino population.</s></p><p xml:id="_Wj6zb8k"><s xml:id="_J2Wpm2C">Digital health technology can improve diabetes medication adherence behavior <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b39">40]</ref> and HbA1c <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b39">40,</ref><ref type="bibr">41]</ref> and is recommended by the American Diabetes Association to support diabetes self-care <ref type="bibr" target="#b41">[42]</ref>.</s><s xml:id="_yeZGnPe">However, among the 90 (approximately) digital health apps currently available for diabetes self-management, only one-third are available in Spanish, of which 94% (90/96) have a readability level above that recommended for patient education material <ref type="bibr" target="#b42">[43]</ref>.</s><s xml:id="_zFbu2zm">Some digital medication adherence support platforms are currently under study in Latino and Spanish-speaking populations <ref type="bibr" target="#b43">[44,</ref><ref type="bibr" target="#b44">45]</ref>.</s><s xml:id="_paKUXhP">However, none of these platforms provide educational content tailored to patient-reported barriers to diabetes medication adherence.</s><s xml:id="_4QAxKdw">The REACH-Español platform adapted in this study offers this key innovation, in addition to health literacy-informed content, which could facilitate broader engagement of prospective participants and long-term medication adherence.</s></p><p xml:id="_MdY2AGp"><s xml:id="_z5NQJch">Our study has the key strength of having adapted an intervention with iterative input from stakeholders who could be representative of the population most likely to use the intervention.</s><s xml:id="_aCDKKVn">This user-centered approach is recommended in diabetes digital health research <ref type="bibr" target="#b45">[46,</ref><ref type="bibr" target="#b46">47]</ref> to ensure that end user perspectives are represented in the development of interventions and content is tailored to user needs.</s><s xml:id="_jtQKta5">However, our study also has several limitations.</s><s xml:id="_e5kXhXe">First, the sample size was relatively small, although we achieved thematic saturation for barrier selection after conducting 3 focus groups.</s><s xml:id="_9WekCsX">Second, we recruited participants from a single health center and did not have representation from every Latin American and Caribbean country, which could limit the generalizability of our findings.</s><s xml:id="_ZpGWxgM">In addition, although the barriers to diabetes medication adherence selected in this study were based on relevance to the focus group participants, the order of relevance may differ in other Latin American populations living elsewhere in the United States or with a different insulin usage profile.</s><s xml:id="_uaPPmqb">For instance, "I have trouble paying for my medicine" was not a highly ranked barrier but this may be an important barrier in other areas of the country with lower insurance coverage.</s><s xml:id="_Bpqahb9">Thus, should the REACH-Español content be adapted to other contexts, using the IMB model to identify population-specific barriers could be helpful.</s><s xml:id="_rspNSYk">Finally, the focus of this study was to adapt the barrier-specific text message content.</s><s xml:id="_QAbZ5hq">While text message content pertaining to diet and physical activity was directly translated from English to Spanish, the content did not undergo the stakeholder-driven adaptation process described here, which will be the subject of a future study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jmw9SkT">Conclusions</head><p xml:id="_ZtmVsuS"><s xml:id="_6u7dmNS">In this study, we report the multiphase, stakeholder-driven adaptation of the REACH digital health platform text message content, which addresses barriers to diabetes medication adherence, to a Latino population with T2D.</s><s xml:id="_kdcgfZS">We found key barriers to diabetes medication adherence that were relevant to this population, largely related to information gaps.</s><s xml:id="_XRUEWFM">These findings can contribute to the fields of patient-important outcomes and treatment burden to guide respectful and meaningful patient engagement in the management of T2D.</s><s xml:id="_twAXkUr">Furthermore, engaging a diverse group of bilingual stakeholders (bilingual research team, focus group participants) early and throughout the iterative adaptation process was integral to ensuring content and linguistic relevance of the text messages in the REACH-Español platform.</s><s xml:id="_6uCekwX">The feasibility, acceptability, usability, and preliminary efficacy of REACH-Español is under study in a 6-month pilot randomized controlled trial, which could broaden our understanding of the role of tailored, digital health interventions on improving diabetes self-care among Latino adults with T2D.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_RSJdfnE"><s xml:id="_xxVzjU8">Figure 1.</s><s xml:id="_5x7Wysz">Adaptation and development of REACH-Español text message content on barriers to diabetes medication adherence (gray boxes outline original adaptation framework proposed by Matias-Carrelo et al [30]; corresponding modifications are shown in the white boxes).</s><s xml:id="_CtFhxxp">REACH: Rapid Encouragement/Education And Communications for Health.</s></p></div></figDesc><graphic coords="4,70.38,105.60,455.50,668.29" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_bpjawW7"><s xml:id="_mZmUrFy">Figure 2. Proportion of participants who reported each diabetes medication adherence barrier as relevant sometimes or always (barriers were shortened to improve readability, please refer to Multimedia Appendix 4 for full barrier wording).</s></p></div></figDesc><graphic coords="7,42.50,187.40,511.25,293.11" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_DbYvPdR"><s xml:id="_rCQtxQ9">Table 1 summarizes the demographic and clinical characteristics of the study participants.</s><s xml:id="_JTRurUT">The mean age was 63.2 (SD 11) years, 55% (10/22) were female, 59% (13/22) were categorized as having high health literacy (based on the 1-item BRIEF questionnaire), although 55% (12/22) reported an educational attainment of elementary or middle school only.</s><s xml:id="_7tYT8tx">Over two-thirds (16/22 73%) of participants were born outside of the United States, largely in Central America.</s><s xml:id="_GXqu9CS">Participants had a mean (SD) diabetes duration of 20.3 (12) years.</s><s xml:id="_PNhYmqt">In addition, 59% (13/22) of participants reported insulin use.</s><s xml:id="_qqAEKpW">Characteristics of the focus group population.</s></p></div></figDesc><table><row><cell>Characteristic</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_j7jUBb4"><s xml:id="_XcNg2cG">Diabetes medication adherence barriers reported by focus group participants (what are some difficulties that you encounter when taking your diabetes medications?).</s></p></div></figDesc><table><row><cell cols="3">Barriers to diabetes medication adherence: What are some difficulties that you encounter when taking your diabetes medications? Themes Participant Quotes IMB a category Existing REACH b barrier</cell></row><row><cell>Medication burden Too many medications and exhaustion with taking medications daily</cell><cell>"It's not difficult to take medications, it's just that we are disgusted by having to take so many El Salvador) rejection [of the medication]." (Female, 45 y old, "Sometimes I don't want it….there is a rejection, a every day." (Female, 45 y old, Guatemala) am exhausted with having to take medications medications." (Female, 62 y old, El Salvador) "I</cell><cell>Personal Motivation I feel burned out with having to take diabetes medicines</cell></row></table><note xml:id="_J6jr9RV"><p><s xml:id="_csm6NA2">a IMB: information-motivation-behavioral skills model.</s><s xml:id="_BAuhCTD">b REACH: Rapid Encouragement/Education And Communications for Health.</s><s xml:id="_TyAVmtm">c N/A:not applicable</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_F4qfUaN"><s xml:id="_u4kuqSD">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_PhdY93X">JMIR Hum Factors 2025 | vol.</s><s xml:id="_cWRvNrk">12 | e66668 | p. 2 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_EXNjDWR"><s xml:id="_SKnDCCk">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_AHDQcfY">JMIR Hum Factors 2025 | vol.</s><s xml:id="_2GbqsZ8">12 | e66668 | p. 3 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_pnkUsx4"><s xml:id="_GgbYZAC">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_FtW69Gd">JMIR Hum Factors 2025 | vol.</s><s xml:id="_YJM7yFC">12 | e66668 | p. 4 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_58uZKVv"><s xml:id="_HMfXvSK">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_6gqsdmg">JMIR Hum Factors 2025 | vol.</s><s xml:id="_rHDXzt8">12 | e66668 | p. 5 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p xml:id="_emYN5rk"><s xml:id="_84hRtga">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_jPcMMRU">JMIR Hum Factors 2025 | vol.</s><s xml:id="_z5xxPsV">12 | e66668 | p. 6 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_5"><p xml:id="_NFR7Kzf"><s xml:id="_vwCaSjA">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_AHr8YRe">JMIR Hum Factors 2025 | vol.</s><s xml:id="_QPs73S3">12 | e66668 | p. 7 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_6"><p xml:id="_45k2CcC"><s xml:id="_hwCNXhF">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_GsfGjte">JMIR Hum Factors 2025 | vol.</s><s xml:id="_cF5aDNc">12 | e66668 | p. 8 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_7"><p xml:id="_9Jteg4C"><s xml:id="_GMr5QT6">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_zrYu5nq">JMIR Hum Factors 2025 | vol.</s><s xml:id="_KUXe4Gc">12 | e66668 | p. 9 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_8"><p xml:id="_svCZVKq"><s xml:id="_XEasC76">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_rYkBTud">JMIR Hum Factors 2025 | vol.</s><s xml:id="_fzxKv63">12 | e66668 | p. 10 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_9"><p xml:id="_BACsmjr"><s xml:id="_CSkJuCW">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_fUBDPbt">JMIR Hum Factors 2025 | vol.</s><s xml:id="_rCQCGj8">12 | e66668 | p. 11 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_10"><p xml:id="_tQxxTYF"><s xml:id="_9YfqxNT">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_twkJ6CA">JMIR Hum Factors 2025 | vol.</s><s xml:id="_UfThyra">12 | e66668 | p. 12 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_11"><p xml:id="_DMn9Sqv"><s xml:id="_waaCsm3">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_mH6aswm">JMIR Hum Factors 2025 | vol.</s><s xml:id="_NwfwmqN">12 | e66668 | p. 13 (page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_12"><p xml:id="_mGKEhJf"><s xml:id="_DEMKa4w">https://humanfactors.jmir.org/2025/1/e66668</s><s xml:id="_b8zfsk2">JMIR Hum Factors 2025 | vol.</s><s xml:id="_MpRgYsE">12 | e66668 | p. 14 (page number not for citation purposes)</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_ZQpkP7B">Acknowledgments</head><p xml:id="_6P77FHW"><s xml:id="_6r8Dc9S">The authors thank the <rs type="institution">MGH Chelsea HealthCare Center</rs> and the <rs type="institution">MGH Diabetes Research Center</rs>, particularly <rs type="person">Mary Larkin</rs>, <rs type="person">Melissa Calverley</rs>, and <rs type="person">Arantxa Medina</rs> for their contributions to this study and for their assistance in organizing the focus groups.</s><s xml:id="_BQtzYgh">JS was supported by grant <rs type="grantNumber">K23DK135798</rs> from the <rs type="funder">National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</rs> and by the <rs type="funder">MGH</rs> <rs type="grantName">Physician-Scientist Development Award</rs>.</s><s xml:id="_kN7asSr">SC was supported by <rs type="funder">American Diabetes Association</rs> grant # <rs type="grantNumber">7-21-JDFM-005</rs>.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_WkZW52u">
					<idno type="grant-number">K23DK135798</idno>
				</org>
				<org type="funding" xml:id="_P7jKgUm">
					<orgName type="grant-name">Physician-Scientist Development Award</orgName>
				</org>
				<org type="funding" xml:id="_rav5sfR">
					<idno type="grant-number">7-21-JDFM-005</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HyHmeCA">Authors' Contributions</head><p xml:id="_JwFj4s8"><s xml:id="_XwucVdG">JS, DW, and LM co-conceived the study.</s><s xml:id="_Ss2zUEc">JS, ST, and RCT conducted the focus groups and collected the data.</s><s xml:id="_PsSj8sy">JS conducted the analysis.</s><s xml:id="_FrFmChq">JS, DW, and LM wrote the first draft of the manuscript, and all authors provided critical inputs on multiple iterations.</s><s xml:id="_RzYNDaK">All authors have approved the final version.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ZARB2hE">Conflicts of Interest</head><p xml:id="_uRXqJX4"><s xml:id="_kFfgvYF">DW reports serving on a data monitoring committee for Novo Nordisk.</s><s xml:id="_bHnrQbx">SC's spouse works for Depuy-Synthes; ad hoc consulting for Alexion Pharmaceuticals, Patients Square Capital, and Wolters-Kluwer.</s><s xml:id="_Apeg4m8">All other authors declare no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Yk7Rmj6">Multimedia Appendix 1</head><p xml:id="_N2hqaVn"><s xml:id="_6JsPAy9">List of REACH barriers and additional barriers from literature search of potential relevance to Spanish-speaking adults with type 2 diabetes (table shows the barriers to diabetes medication adherence used in the original REACH intervention, mapped into the Information Motivation Behavioral skills model; additional barriers with described relevance to Spanish-speaking adults with type 2 diabetes are shown in gray).</s></p><p xml:id="_HYVJTYv"><s xml:id="_Rw7vjmb">[DOCX File (Microsoft Word File), 15 KB-Multimedia Appendix 1]</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qyUeVZM">Multimedia Appendix 2</head><p xml:id="_5WZDhcJ"><s xml:id="_ZGj8mCQ">Condensed list of barriers used in focus groups 1-3 (table shows the barriers to diabetes medication adherence used in the adaptation of REACH to REACH-Español.</s><s xml:id="_YzVcAMd">The 9 barriers that were identified in the literature with potential relevance for Latino adults with type 2 diabetes were added to the list and combined with similar REACH barriers [gray]).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_zta3h3v">Multimedia Appendix 4</head><p xml:id="_Jq9SufG"><s xml:id="_GY6DkFU">Barriers to diabetes medication adherence assessed in focus groups conducted with Latino adults with type 2 diabetes and corresponding proportion of participants who reported that the barrier was relevant sometimes or always.</s></p><p xml:id="_wU2MNAF"><s xml:id="_MvpJnV5">[DOCX File (Microsoft Word File), 17 KB-Multimedia Appendix 4]</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gU6N6KJ">Multimedia Appendix 5</head><p xml:id="_AB6Q4VF"><s xml:id="_QC4vePM">Focus group activity to elicit participant input regarding text message content and language.</s><s xml:id="_zftfHXr">Yes (Si) and No banners were used by participants to prompt discussion on text message content and language.</s></p><p xml:id="_GCG6xUT"><s xml:id="_rNpXQ4j">[DOCX File (Microsoft Word File), 206 KB-Multimedia Appendix 5]</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bRuHq22">Multimedia Appendix 6</head><p xml:id="_nsyDg6p"><s xml:id="_pmgySks">Facilitators to diabetes medication adherence based on thematic content analysis.</s></p><p xml:id="_c9TnVC2"><s xml:id="_jKVsf4F">[DOCX File (Microsoft Word File), <ref type="bibr" target="#b13">14</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_y3bPrNb">Longitudinal effects of medication nonadherence on glycemic control</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Egede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gebregziabher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Echols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Lynch</surname></persName>
		</author>
		<idno type="DOI">10.1177/1060028014526362</idno>
		<idno>Medline: 24586059</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rrdaAtH">Ann Pharmacother</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="562" to="570" />
			<date type="published" when="2014-05">May 2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. May 2014;48(5):562-570. [doi: 10.1177/1060028014526362] [Medline: 24586059]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_VaYZrkQ">Measuring insulin adherence among adults with type 2 diabetes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Osborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Gonzalez</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10865-016-9741-y</idno>
		<idno>Medline: 27062271</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nJKwT3r">J Behav Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="633" to="641" />
			<date type="published" when="2016-08">Aug 2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Osborn CY, Gonzalez JS. Measuring insulin adherence among adults with type 2 diabetes. J Behav Med. Aug 2016;39(4):633-641. [doi: 10.1007/s10865-016-9741-y] [Medline: 27062271]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_eAKmz5r">Adherence to oral antidiabetic drugs in patients with type 2 diabetes: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Piragine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Petri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Martelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Calderone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lucenteforte</surname></persName>
		</author>
		<idno type="DOI">10.3390/jcm12051981</idno>
		<idno>Medline: 36902770</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VxbjhMX">J Clin Med. Mar</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">1981</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Piragine E, Petri D, Martelli A, Calderone V, Lucenteforte E. Adherence to oral antidiabetic drugs in patients with type 2 diabetes: systematic review and meta-analysis. J Clin Med. Mar 2, 2023;12(5):1981. [doi: 10.3390/jcm12051981] [Medline: 36902770]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_aH7MNvs">Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Aiken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Sloane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bruyneel</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(13)62631-8</idno>
		<idno>Medline: 24581683</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_S2uw8HX">Lancet. May</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1824" to="1830" />
			<date type="published" when="2014">2014. 9931</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Aiken LH, Sloane DM, Bruyneel L, et al. Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study. Lancet. May 24, 2014;383(9931):1824-1830. [doi: 10.1016/S0140- 6736(13)62631-8] [Medline: 24581683]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_E4cdSAS">Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Rumsfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Masoudi</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.166.17.1836</idno>
		<idno>Medline: 17000939</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZuChGyE">Arch Intern Med. Sep</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1836" to="1841" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. Sep 25, 2006;166(17):1836-1841. [doi: 10.1001/archinte.166.17.1836] [Medline: 17000939]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_KFwbdeb">Health literacy explains racial disparities in diabetes medication adherence</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Osborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cavanaugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Wallston</surname></persName>
		</author>
		<idno type="DOI">10.1080/10810730.2011.604388</idno>
		<idno>Medline: 21951257</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a2BYAnn">J Health Commun</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">Suppl 3</biblScope>
			<biblScope unit="page" from="268" to="278" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Osborn CY, Cavanaugh K, Wallston KA, et al. Health literacy explains racial disparities in diabetes medication adherence. J Health Commun. 2011;16 Suppl 3(Suppl 3):268-278. [doi: 10.1080/10810730.2011.604388] [Medline: 21951257]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_9hqgtZy">Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Thumula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Pace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Banahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Wilkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Lobb</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.clinthera.2009.10.002</idno>
		<idno>Medline: 19922889</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_y5EADtV">Clin Ther</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2178" to="2188" />
			<date type="published" when="2009-10">Oct 2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yang Y, Thumula V, Pace PF, Banahan BF, Wilkin NE, Lobb WB. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther. Oct 2009;31(10):2178-2188. [doi: 10.1016/j.clinthera.2009.10.002] [Medline: 19922889]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_mMkEQxg">Adherence to newly prescribed diabetes medications among insured Latino and White patients with diabetes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fernández</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Quan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Moffet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schillinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Karter</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2016.8653</idno>
		<idno>Medline: 28114642</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_76wZFAq">JAMA Intern Med. Mar</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="371" to="379" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fernández A, Quan J, Moffet H, Parker MM, Schillinger D, Karter AJ. Adherence to newly prescribed diabetes medications among insured Latino and White patients with diabetes. JAMA Intern Med. Mar 1, 2017;177(3):371-379. [doi: 10.1001/jamainternmed.2016.8653] [Medline: 28114642]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_zqXk2jd">Factors impacting adherence to diabetes medication among urban, low income Mexican-Americans with diabetes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Baghikar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Benitez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fernandez Piñeros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Baig</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10903-019-00867-9</idno>
		<idno>Medline: 30798408</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ps7twQn">J Immigr Minor Health</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1334" to="1341" />
			<date type="published" when="2019-12">Dec 2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Baghikar S, Benitez A, Fernandez Piñeros P, Gao Y, Baig AA. Factors impacting adherence to diabetes medication among urban, low income Mexican-Americans with diabetes. J Immigr Minor Health. Dec 2019;21(6):1334-1341. [doi: 10.1007/s10903-019-00867-9] [Medline: 30798408]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_WcjhPAD">Assessing barriers to medication adherence in underserved patients with diabetes in Texas</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Barner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Weems</surname></persName>
		</author>
		<idno type="DOI">10.1177/0145721711436134</idno>
		<idno>Medline: 22316643</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k8fJAmy">Diabetes Educ</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="271" to="279" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bailey GR, Barner JC, Weems JK, et al. Assessing barriers to medication adherence in underserved patients with diabetes in Texas. Diabetes Educ. 2012;38(2):271-279. [doi: 10.1177/0145721711436134] [Medline: 22316643]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_Byfezfn">Assessing barriers to medication adherence among Latinos with diabetes: a cross-sectional study</title>
		<author>
			<persName><forename type="first">Banuelos</forename><surname>Mota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Feliz</forename><surname>Sala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Perdomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename></persName>
		</author>
		<idno type="DOI">10.1007/s11606-019-05041-3</idno>
		<idno>Medline: 31161564</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hgMXeqX">J GEN INTERN MED</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="603" to="605" />
			<date type="published" when="2020-02">Feb 2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Banuelos Mota A, Feliz Sala EE, Perdomo JM, et al. Assessing barriers to medication adherence among Latinos with diabetes: a cross-sectional study. J GEN INTERN MED. Feb 2020;35(2):603-605. [doi: 10.1007/s11606-019-05041-3] [Medline: 31161564]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_GrNM7pp">Costs and beliefs: understanding individual-and neighborhood-level correlates of medication nonadherence among Mexican Americans with type 2 diabetes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Billimek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>August</surname></persName>
		</author>
		<idno type="DOI">10.1037/hea0000020</idno>
		<idno>Medline: 24295022</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v4ZrUc8">Health Psychol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1602" to="1605" />
			<date type="published" when="2014-12">Dec 2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Billimek J, August KJ. Costs and beliefs: understanding individual-and neighborhood-level correlates of medication nonadherence among Mexican Americans with type 2 diabetes. Health Psychol. Dec 2014;33(12):1602-1605. [doi: 10. 1037/hea0000020] [Medline: 24295022]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_TY8m5WP">Predictors of medication adherence in an urban Latino community with healthcare disparities</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Colby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chhabra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pérez-Escamilla</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10903-011-9545-7</idno>
		<idno>Medline: 22069023</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GU6TQWG">J Immigr Minor Health</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="589" to="595" />
			<date type="published" when="2012-08">Aug 2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Colby JA, Wang F, Chhabra J, Pérez-Escamilla R. Predictors of medication adherence in an urban Latino community with healthcare disparities. J Immigr Minor Health. Aug 2012;14(4):589-595. [doi: 10.1007/s10903-011-9545-7] [Medline: 22069023]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_SKgjHHU">Perceptions of barriers in managing diabetes: perspectives of Hispanic immigrant patients and family members</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Amirehsani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Letvak</surname></persName>
		</author>
		<idno type="DOI">10.1177/0145721713486200</idno>
		<idno>Medline: 23640301</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WvtfJzZ">Diabetes Educ</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="494" to="503" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hu J, Amirehsani K, Wallace DC, Letvak S. Perceptions of barriers in managing diabetes: perspectives of Hispanic immigrant patients and family members. Diabetes Educ. 2013;39(4):494-503. [doi: 10.1177/0145721713486200] [Medline: 23640301]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_VdKcy9B">Factors associated with diabetes control in predominately African American and Hispanic population with newly diagnosed type 2 diabetes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Morkos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tahsin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fogelfeld</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40615-020-00785-9</idno>
		<idno>Medline: 32557276</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PXxB9ht">J Racial Ethn Health Disparities</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="332" to="338" />
			<date type="published" when="2021-04">Apr 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morkos M, Tahsin B, Fogelfeld L. Factors associated with diabetes control in predominately African American and Hispanic population with newly diagnosed type 2 diabetes. J Racial Ethn Health Disparities. Apr 2021;8(2):332-338. [doi: 10.1007/s40615-020-00785-9] [Medline: 32557276]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_uWeTKyu">Myths and misconceptions about insulin therapy among Latinos/ Hispanics with diabetes: a fresh look at an old problem</title>
		<author>
			<persName><forename type="first">Andreina</forename><surname>Millan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename></persName>
		</author>
		<idno type="DOI">10.4172/2155-6156.1000482</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SUvqbXx">J Diabetes Metab</title>
		<imprint>
			<biblScope unit="volume">06</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="5" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Andreina Millan RR. Myths and misconceptions about insulin therapy among Latinos/ Hispanics with diabetes: a fresh look at an old problem. J Diabetes Metab. 2015;06(1):1-5. [doi: 10.4172/2155-6156.1000482]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_9FJ2trb">Adherence to diabetes self-care behaviors in English-and Spanish-speaking Hispanic men</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">O</forename><surname>Rustveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Pavlik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Jibaja-Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Kline</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Gossey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Volk</surname></persName>
		</author>
		<idno type="DOI">10.2147/ppa.s5383</idno>
		<idno>Medline: 19936154</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jg8m8D7">Patient Prefer Adherence</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="123" to="130" />
			<date type="published" when="2009-11-03">Nov 3, 2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rustveld LO, Pavlik VN, Jibaja-Weiss ML, Kline KN, Gossey JT, Volk RJ. Adherence to diabetes self-care behaviors in English-and Spanish-speaking Hispanic men. Patient Prefer Adherence. Nov 3, 2009;3:123-130. [doi: 10.2147/ppa. s5383] [Medline: 19936154]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_BjcJx93">Diabetes affects everything: type 2 diabetes self-management among Spanishspeaking hispanic immigrants</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Smith-Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.1002/nur.21817</idno>
		<idno>Medline: 28877552</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JA4qrDU">Res Nurs Health</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="541" to="554" />
			<date type="published" when="2017-12">Dec 2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smith-Miller CA, Berry DC, Miller CT. Diabetes affects everything: type 2 diabetes self-management among Spanish- speaking hispanic immigrants. Res Nurs Health. Dec 2017;40(6):541-554. [doi: 10.1002/nur.21817] [Medline: 28877552]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_6bQx7zm">Effects of limited English proficiency and physician language on health care comprehension</title>
		<author>
			<persName><forename type="first">E</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ahm</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Grumbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fernandez</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1525-1497.2005.0174.x</idno>
		<idno>Medline: 16117746</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2K32AkE">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="800" to="806" />
			<date type="published" when="2005-09">Sep 2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wilson E, Chen AHM, Grumbach K, Wang F, Fernandez A. Effects of limited English proficiency and physician language on health care comprehension. J Gen Intern Med. Sep 2005;20(9):800-806. [doi: 10.1111/j.1525-1497.2005. 0174.x] [Medline: 16117746]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_cyd3k42">The messaging for diabetes intervention reduced barriers to medication adherence among low-income, diverse adults with type 2</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Mayberry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Mulvaney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Osborn</surname></persName>
		</author>
		<idno type="DOI">10.1177/1932296816668374</idno>
		<idno>Medline: 27595710</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mTUFG7Z">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="92" to="99" />
			<date type="published" when="2017-01">Jan 2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mayberry LS, Mulvaney SA, Johnson KB, Osborn CY. The messaging for diabetes intervention reduced barriers to medication adherence among low-income, diverse adults with type 2. J Diabetes Sci Technol. Jan 2017;11(1):92-99. [doi: 10.1177/1932296816668374] [Medline: 27595710]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_eQ9ZQ2Z">Effects of a tailored text messaging intervention among diverse adults with type 2 diabetes: evidence from the 15-month REACH randomized controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Greevy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spieker</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc20-0961</idno>
		<idno>Medline: 33154039</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9AvDeGw">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="26" to="34" />
			<date type="published" when="2021-01">Jan 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nelson LA, Greevy RA, Spieker A, et al. Effects of a tailored text messaging intervention among diverse adults with type 2 diabetes: evidence from the 15-month REACH randomized controlled trial. Diabetes Care. Jan 2021;44(1):26-34. [doi: 10.2337/dc20-0961] [Medline: 33154039]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_TsuWsyB">Predicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical research</title>
		<author>
			<persName><forename type="first">Eaf</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Morrison</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jval.2014.08.2671</idno>
		<idno>Medline: 25498782</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YQWqW7G">Value Health</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="863" to="876" />
			<date type="published" when="2014-12">Dec 2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Holmes EAF, Hughes DA, Morrison VL. Predicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical research. Value Health. Dec 2014;17(8):863-876. [doi: 10.1016/j.jval.2014. 08.2671] [Medline: 25498782]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_Kze2JX6">Empirical validation of the information-motivation-behavioral skills of diabetes medication adherence: a framework for intervention</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Mayberry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Osborn</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc13-1828</idno>
		<idno>Medline: 24598245</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xueuVs6">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1246" to="1253" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mayberry LS, Osborn CY. Empirical validation of the information-motivation-behavioral skills of diabetes medication adherence: a framework for intervention. Diabetes Care. 2014;37(5):1246-1253. [doi: 10.2337/dc13-1828] [Medline: 24598245]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_reFVNPZ">Validation of an information-motivation-behavioral skills model of diabetes self-care (IMB-DSC)</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Osborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Egede</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pec.2009.07.016</idno>
		<idno>Medline: 19699601</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_e2xJHkX">Patient Educ Couns</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="49" to="54" />
			<date type="published" when="2010-04">Apr 2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Osborn CY, Egede LE. Validation of an information-motivation-behavioral skills model of diabetes self-care (IMB- DSC). Patient Educ Couns. Apr 2010;79(1):49-54. [doi: 10.1016/j.pec.2009.07.016] [Medline: 19699601]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_NkV63ej">Assessing barriers to diabetes medication adherence using the Information-Motivation-Behavioral skills model</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Wallston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kripalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Lestourgeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Mayberry</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2018.05.046</idno>
		<idno>Medline: 29879495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xbXHgdN">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="374" to="384" />
			<date type="published" when="2018-08">Aug 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nelson LA, Wallston KA, Kripalani S, LeStourgeon LM, Williamson SE, Mayberry LS. Assessing barriers to diabetes medication adherence using the Information-Motivation-Behavioral skills model. Diabetes Res Clin Pract. Aug 2018;142:374-384. [doi: 10.1016/j.diabres.2018.05.046] [Medline: 29879495]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_gznq3tm">Development and usability of REACH: a tailored theory-based text messaging intervention for disadvantaged adults with type 2 diabetes</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Mayberry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wallston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kripalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Bergner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Osborn</surname></persName>
		</author>
		<idno type="DOI">10.2196/humanfactors.6029</idno>
		<idno>Medline: 27609738</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PBjKV2r">JMIR Hum Factors</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">23</biblScope>
			<date type="published" when="2016-09-08">Sep 8, 2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nelson LA, Mayberry LS, Wallston K, Kripalani S, Bergner EM, Osborn CY. Development and usability of REACH: a tailored theory-based text messaging intervention for disadvantaged adults with type 2 diabetes. JMIR Hum Factors. Sep 8, 2016;3(2):e23. [doi: 10.2196/humanfactors.6029] [Medline: 27609738]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_z2uCKT8">User engagement among diverse adults in a 12-month text message-delivered diabetes support intervention: results from a randomized controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spieker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Greevy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Lestourgeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Wallston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Mayberry</surname></persName>
		</author>
		<idno type="DOI">10.2196/17534</idno>
		<idno>Medline: 32706738</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TVWbhdv">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">17534</biblScope>
			<date type="published" when="2020-07-21">Jul 21, 2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nelson LA, Spieker A, Greevy R, LeStourgeon LM, Wallston KA, Mayberry LS. User engagement among diverse adults in a 12-month text message-delivered diabetes support intervention: results from a randomized controlled trial. JMIR Mhealth Uhealth. Jul 21, 2020;8(7):e17534. [doi: 10.2196/17534] [Medline: 32706738]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">S</forename><surname>Census</surname></persName>
		</author>
		<author>
			<persName><surname>Bureau</surname></persName>
		</author>
		<idno type="DOI">10.1037/e386072004-001</idno>
		<ptr target="https://www.census.gov/quickfacts/fact/table/chelseacitymassachusetts/PST045223" />
		<title level="m" xml:id="_Wfc6n9k">QuickFacts: chelsea city, massachusetts</title>
		<imprint>
			<date type="published" when="2024">2024. 2025-04-21</date>
		</imprint>
	</monogr>
	<note type="raw_reference">U.S. Census Bureau. QuickFacts: chelsea city, massachusetts. 2024. URL: https://www.census.gov/quickfacts/fact/table/ chelseacitymassachusetts/PST045223 [Accessed 2025-04-21]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_SV4F8jv">Brief screening items to identify spanish-speaking adults with limited health literacy and numeracy skills</title>
		<author>
			<persName><forename type="first">R</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Coyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Wallace</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12913-015-1046-2</idno>
		<idno>Medline: 26370120</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K5u66sj">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">374</biblScope>
			<date type="published" when="2015-09-14">Sep 14. 2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Singh R, Coyne LS, Wallace LS. Brief screening items to identify spanish-speaking adults with limited health literacy and numeracy skills. BMC Health Serv Res. Sep 14, 2015;15:374. [doi: 10.1186/s12913-015-1046-2] [Medline: 26370120]</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_nRvn5cK">The Spanish translation and cultural adaptation of five mental health outcome measures</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Matías-Carrelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Chávez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Negrón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Canino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aguilar-Gaxiola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hoppe</surname></persName>
		</author>
		<idno type="DOI">10.1023/a:1025399115023</idno>
		<idno>Medline: 14510096</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fyQsYjy">Cult Med Psychiatry</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="291" to="313" />
			<date type="published" when="2003-09">Sep 2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Matías-Carrelo LE, Chávez LM, Negrón G, Canino G, Aguilar-Gaxiola S, Hoppe S. The Spanish translation and cultural adaptation of five mental health outcome measures. Cult Med Psychiatry. Sep 2003;27(3):291-313. [doi: 10.1023/a: 1025399115023] [Medline: 14510096]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_WUuNVwA">Safety vs price in the generic drug market: metformin</title>
		<author>
			<persName><forename type="first">B</forename><surname>Teasdale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hudspeth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kucera</surname></persName>
		</author>
		<idno type="DOI">10.37765/ajmc.2024.89450</idno>
		<idno>Medline: 38603530</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AQDDPM3">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="161" to="168" />
			<date type="published" when="2024-04">Apr 2024</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Teasdale B, Hudspeth A, Kucera K, et al. Safety vs price in the generic drug market: metformin. Am J Manag Care. Apr 2024;30(4):161-168. [doi: 10.37765/ajmc.2024.89450] [Medline: 38603530]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_srsRk7X">Translation and cultural adaptation of a mental health outcome measure: the BASIS-R(c)</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Cortés</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gerena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Canino</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11013-006-9043-x</idno>
		<idno>Medline: 17219078</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VCNxVft">Cult Med Psychiatry</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="49" />
			<date type="published" when="2007-03">Mar 2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cortés DE, Gerena M, Canino G, et al. Translation and cultural adaptation of a mental health outcome measure: the BASIS-R(c). Cult Med Psychiatry. Mar 2007;31(1):25-49. [doi: 10.1007/s11013-006-9043-x] [Medline: 17219078]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_tvXv4sT">Cultural adaptation and health literacy refinement of a brief depression intervention for Latinos in a low-resource setting</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Ramos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alegría</surname></persName>
		</author>
		<idno type="DOI">10.1037/a0035021</idno>
		<idno>Medline: 24588455</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kw4JA29">Cultur Divers Ethnic Minor Psychol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="293" to="301" />
			<date type="published" when="2014-04">Apr 2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ramos Z, Alegría M. Cultural adaptation and health literacy refinement of a brief depression intervention for Latinos in a low-resource setting. Cultur Divers Ethnic Minor Psychol. Apr 2014;20(2):293-301. [doi: 10.1037/a0035021] [Medline: 24588455]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_p2yEpm7">Mediators and moderators of improvement in medication adherence: secondary analysis of a community health worker-led diabetes medication self-management support program</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fagerlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Spencer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heisler</surname></persName>
		</author>
		<idno type="DOI">10.1177/1090198116656331</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vBtnkjp">Health Educ Behav Off Publ Soc Public Health Educ</title>
		<imprint>
			<biblScope unit="page" from="285" to="296" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hofer R, Choi H, Mase R, Fagerlin A, Spencer M, Heisler M. Mediators and moderators of improvement in medication adherence: secondary analysis of a community health worker-led diabetes medication self-management support program. Health Educ Behav Off Publ Soc Public Health Educ. 2017:285-296. [doi: 10.1177/1090198116656331]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_sskaSRn">A brief culturally tailored intervention for Puerto Ricans with type 2 diabetes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Osborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Amico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cruz</surname></persName>
		</author>
		<idno type="DOI">10.1177/1090198110366004</idno>
		<idno>Medline: 21076128</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BJAZWFC">Health Educ Behav</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="849" to="862" />
			<date type="published" when="2010-12">Dec 2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Osborn CY, Amico KR, Cruz N, et al. A brief culturally tailored intervention for Puerto Ricans with type 2 diabetes. Health Educ Behav. Dec 2010;37(6):849-862. [doi: 10.1177/1090198110366004] [Medline: 21076128]</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_taMwUfD">Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Eton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Ridgeway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Egginton</surname></persName>
		</author>
		<idno type="DOI">10.2147/prom.s78955</idno>
		<idno>Medline: 25848328</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KSwqPQR">Patient Relat Outcome Meas</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="117" to="126" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Eton DT, Ridgeway JL, Egginton JS, et al. Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions. Patient Relat Outcome Meas. 2015;6:117-126. [doi: 10.2147/PROM.S78955] [Medline: 25848328]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_yt7Nh8K">Beyond hemoglobin A1c: a videographic analysis of conversations about quality of life and treatment burden during clinical encounters for diabetes care</title>
		<author>
			<persName><forename type="first">S</forename><surname>Haider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">El</forename><surname>Kawkgi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<idno type="DOI">10.1007/s12020-021-02757-3</idno>
		<idno>Medline: 34189680</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RGgvQ3Q">Endocrine</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="573" to="579" />
			<date type="published" when="2021-09">Sep 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haider S, El Kawkgi O, Clark J, et al. Beyond hemoglobin A1c: a videographic analysis of conversations about quality of life and treatment burden during clinical encounters for diabetes care. Endocrine. Sep 2021;73(3):573-579. [doi: 10. 1007/s12020-021-02757-3] [Medline: 34189680]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_rmvcenQ">Mental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Sorkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Billimek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>August</surname></persName>
		</author>
		<idno type="DOI">10.1093/fampra/cmv014</idno>
		<idno>Medline: 25846216</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ngqhXWz">Fam Pract</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="317" to="322" />
			<date type="published" when="2015-06">Jun 2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sorkin DH, Billimek J, August KJ, et al. Mental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes. Fam Pract. Jun 2015;32(3):317-322. [doi: 10.1093/fampra/cmv014] [Medline: 25846216]</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_XGfjy3H">Patient work and treatment burden in type 2 diabetes: a mixed-methods study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Spencer-Bonilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Serrano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gao</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mayocpiqo.2021.01.006</idno>
		<idno>Medline: 33997635</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pq2j3Cb">Mayo Clin Proc Innov Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="359" to="367" />
			<date type="published" when="2021-04">Apr 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Spencer-Bonilla G, Serrano V, Gao C, et al. Patient work and treatment burden in type 2 diabetes: a mixed-methods study. Mayo Clin Proc Innov Qual Outcomes. Apr 2021;5(2):359-367. [doi: 10.1016/j.mayocpiqo.2021.01.006] [Medline: 33997635]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_YdetRDE">Mobile app interventions to improve medication adherence among type 2 diabetes mellitus patients: a systematic review of clinical trials</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Shrivastava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goswami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Goyal</surname></persName>
		</author>
		<idno type="DOI">10.1177/19322968211060060</idno>
		<idno>Medline: 34861793</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VEXUMmb">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="458" to="466" />
			<date type="published" when="2023-03">Mar 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shrivastava TP, Goswami S, Gupta R, Goyal RK. Mobile app interventions to improve medication adherence among type 2 diabetes mellitus patients: a systematic review of clinical trials. J Diabetes Sci Technol. Mar 2023;17(2):458-466. [doi: 10.1177/19322968211060060] [Medline: 34861793</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_jvhqmvD">Telephone intervention to improve diabetes control: a randomized trial in the New York City A1c Registry</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chamany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Schechter</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2015.04.016</idno>
		<idno>Medline: 26232903</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QHwk52t">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="832" to="841" />
			<date type="published" when="2015-12">Dec 2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chamany S, Walker EA, Schechter CB, et al. Telephone intervention to improve diabetes control: a randomized trial in the New York City A1c Registry. Am J Prev Med. Dec 2015;49(6):832-841. [doi: 10.1016/j.amepre.2015.04.016] [Medline: 26232903]</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_BXuwaG2">7. Diabetes technology: standards of care in diabetes-2024</title>
		<idno type="DOI">10.2337/dc24-s007</idno>
		<idno>Medline: 38078575</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_f4EDPvC">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">Suppl 1</biblScope>
			<biblScope unit="page" from="126" to="S144" />
			<date type="published" when="2024-01-01">Jan 1, 2024</date>
			<publisher>American Diabetes Association Professional Practice Committee</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">American Diabetes Association Professional Practice Committee. 7. Diabetes technology: standards of care in diabetes-2024. Diabetes Care. Jan 1, 2024;47(Suppl 1):S126-S144. [doi: 10.2337/dc24-S007] [Medline: 38078575]</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_2n9Wg7p">The Spanish availability and readability of diabetes apps</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Singh</surname></persName>
		</author>
		<idno type="DOI">10.1177/1932296817749610</idno>
		<idno>Medline: 29291639</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RwVu8d4">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="719" to="724" />
			<date type="published" when="2018-05">May 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rodriguez JA, Singh K. The Spanish availability and readability of diabetes apps. J Diabetes Sci Technol. May 2018;12(3):719-724. [doi: 10.1177/1932296817749610] [Medline: 29291639]</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_ZvJDUyZ">Innovative diabetes interventions in the U.S. Hispanic population</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Fortmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Savin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Philis</forename><forename type="middle">-</forename><surname>Tsimikas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename></persName>
		</author>
		<idno type="DOI">10.2337/ds19-0006</idno>
		<idno>Medline: 31798285</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AcCxbSX">Diabetes Spectr</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="295" to="301" />
			<date type="published" when="2019-11">Nov 2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fortmann AL, Savin KL, Clark TL, Philis-Tsimikas A, Gallo LC. Innovative diabetes interventions in the U.S. Hispanic population. Diabetes Spectr. Nov 2019;32(4):295-301. [doi: 10.2337/ds19-0006] [Medline: 31798285]</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_8tu7Cqt">Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes</title>
		<author>
			<persName><forename type="first">Philis-Tsimikas A</forename><surname>Fortmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Godino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename></persName>
		</author>
		<idno type="DOI">10.1186/s13063-021-05899-x</idno>
		<idno>Medline: 35090520</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CdyFkSy">Trials. Jan</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">80</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Philis-Tsimikas A, Fortmann AL, Godino JG, et al. Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes. Trials. Jan 28, 2022;23(1):80. [doi: 10.1186/ s13063-021-05899-x] [Medline: 35090520]</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_pQkx4b6">A patient-facing diabetes dashboard embedded in a patient web portal: design sprint and usability testing</title>
		<author>
			<persName><forename type="first">W</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Threatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Rosenbloom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Wallston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Hickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Elasy</surname></persName>
		</author>
		<idno type="DOI">10.2196/humanfactors.9569</idno>
		<idno>Medline: 30249579</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aBfnx2X">JMIR Hum Factors</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">26</biblScope>
			<date type="published" when="2018-09-24">Sep 24, 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Martinez W, Threatt AL, Rosenbloom ST, Wallston KA, Hickson GB, Elasy TA. A patient-facing diabetes dashboard embedded in a patient web portal: design sprint and usability testing. JMIR Hum Factors. Sep 24, 2018;5(3):e26. [doi: 10.2196/humanfactors.9569] [Medline: 30249579]</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_Ahs8apU">Chapter 4 -agile science: what and how in digital diabetes research</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Threatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">William</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Swa</forename><surname>Mayberry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename></persName>
		</author>
		<idno type="DOI">10.1016/b978-0-12-817485-2.00004-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xFSpxyX">Diabetes Digital Health</title>
		<editor>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Klonoff</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><surname>Kerr</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Mulvaney</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="page" from="51" to="63" />
			<date type="published" when="2020">2020</date>
			<publisher>Elsevier</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Nelson LA, Threatt AL, William Martinez SWA, Mayberry LS. Chapter 4 -agile science: what and how in digital diabetes research. In: Klonoff DC, Kerr D, Mulvaney SA, editors. Diabetes Digital Health. Elsevier; 2020:51-63. [doi: 10.1016/B978-0-12-817485-2.00004-3]</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
